Why One Korean Biotech Picked New Jersey for U.S. Headquarters

July 5, 2018
Michelle Maskaly
Michelle Maskaly

Michelle Maskaly is Pharmaceutical Executive's Senior Editor. Follow her on Twitter @mmaskaly or email her at michelle.maskaly@ubm.com

Pharmaceutical Executive

New Jersey is still a top pick for companies when it comes to pharma.

Ki-Young Sohn, chairman and CEO of Enzychem Lifesciences, explains why the company selected New Jersey as the location for their U.S. offices.

He spoke to Pharm Exec during a company event in New York City.

 

Related Content:

Global | Pharm Exec Video